Union Sues J&J Over Off-Label Uses Of Risperdal

Law360, New York (June 6, 2007, 12:00 AM EDT) -- Pharmaceutical company Johnson & Johnson has been slapped with another lawsuit over its popular anti-psychotic Risperdal, this one alleging that the company attempted to market the drug for nonapproved uses.

The case, filed on Tuesday in the U.S. District Court for the District of New Jersey by the International Brotherhood of Electrical Workers Local 98, claims that J&J sold the Risperdal for “off-label” uses. In addition, the suit alleges that the drug maker “created, monitored and/or controlled various marketing firms, physicians and ghostwriters to promote and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.